Tag: valoctocogene roxaparvovec
No posts to display
News
Ipsen and Skyhawk Therapeutics form RNA targeting research collaboration in rare neurological diseases
Ipsen and Skyhawk Therapeutics have signed an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases.
The...
Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced...
Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...
U.S. FDA approves subcutaneous administration of Takeda’s ENTYVIO for Crohn’s disease
The U.S. Food and Drug Administration (FDA) has approved Takeda's ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely...
